Clinical trial for OCD
Official title Neuromodulation for a Novel OCD Biomarker and Treatment
ClinicalTrials.gov ID: NCT05994053
What this study is testing
- What it's testing
- The study wants to see if a new brain‑stimulation technique can quickly and sustainably lower OCD symptoms, and to learn more about how OCD works in the brain.
- Who it's for
- Adults who have OCD and may not have responded well to other treatments.
- What's involved
- Participants will receive a series of brain‑stimulation sessions guided by brain‑wave recordings, along with regular check‑ups and symptom assessments.
- Time commitment
- The study lasts about a month of treatment with follow‑up visits for up to three months to track symptom changes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- (1) a primary DSM-5 diagnosis of OCD, (2) a score of 16 or greater on the YBOCS (3) at least 18 years of age
You likely can't join if
- (1) a lifetime history of bipolar or psychotic disorders; (2) history of Tourette syndrome; (3) psychosurgery
The study team makes the final eligibility decision.
Where it is enrolling
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Boston, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.